Chartwell Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.31M | Sell |
6,002
-104
| -2% | -$109K | 0.22% | 152 |
|
|
2024
Q2 | $6.42M | Buy |
6,106
+1,832
| +43% | +$1.93M | 0.23% | 149 |
|
|
2024
Q1 | $4.11M | Sell |
4,274
-119
| -3% | -$115K | 0.14% | 211 |
|
|
2023
Q4 | $3.86M | Buy |
4,393
+1,311
| +43% | +$1.15M | 0.14% | 220 |
|
|
2023
Q3 | $2.54M | Sell |
3,082
-89
| -3% | -$73.2K | 0.1% | 249 |
|
|
2023
Q2 | $2.28M | Buy |
3,171
+1,225
| +63% | +$880K | 0.08% | 265 |
|
|
2023
Q1 | $1.6M | Buy |
+1,946
| New | +$1.6M | 0.06% | 299 |
|